Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of Illingworth Research Group™, a leading provider of clinical ...

An awful day for the stock market turned into a terrible one for shares of Syneos Health (SYNH), which fell 13.7%. This slide was driven by an operational update provided during an investor ...

May 10 (Reuters) - An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc (SYNH.O), opens new tab ...

Feb 27 (Reuters) - Syneos Health Inc (SYNH.O), opens new tab is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a ...

MORRISVILLE – Syneos Health is now a private company, having wrapped up its deal valued at some $7 billion with private equity partners Elliott Investment Management L.P., Patient Square ...

Syneos Health, a leading biopharmaceutical contract research organization, agreed to be acquired for $7.1 billion by a group of private equity firms. Elliott Investment Management, Patient Square ...

Syneos Health is a global provider of end-to-end biopharmaceutical outsourcing solutions. The Company operates through two segments, Clinical Solutions and Commercial Solutions, and provides a ...

The multi-billion dollar deal to acquire Syneos Health comes amid an earnings slump for the company as the life sciences industry faces mounting headwinds. Report: $5B Triangle firm eyes sale amid ...

In December, Syneos extended its partnership with Medable that was first signed in 2021 in an effort to boost decentralized clinical trials and improve patient diversity. Under that agreement ...

Syneos Health cemented a multi-year deal to use Microsoft’s platform for deploying artificial intelligence (AI) in its clinical trials and commercial programs. The agreement announced this week ...

Syneos Health appointed Costa Panagos as CEO on Wednesday morning. The integrated biopharma solutions company announced that Panagos will join the board of directors and succeed Colin Shannon, ...